Search the Newsreel

Vivmark Residential to unite AvalonBay (NYSE: AVB) and Equity Residential

AvalonBay Communities (NYSE: AVB) and Equity Residential (NYSE: EQR) have announced that their planned merger of equals will create a combined multifamily REIT named Vivmark Residential. The new entity will have a pro forma equity market capitalization of approximately $53 billion and an enterprise …

Valor Gold Corp. (TSX:VGC) Shares Decline as Exploration Uncertainty, Gold Project Risks and Junior Mining Volatility Pressure Investor Sentiment

Avalo Therapeutics earnings up next: Pipeline progress in focus By Investing.com

Avalo Therapeutics is set to report Q2 earnings, with investors keenly focused on the progress of its hidradenitis suppurativa treatment, abdakibart, towards pivotal trials. Despite an expected loss, the company's stock has significantly risen, and analysts maintain a strong buy rating with substantial upside …

AvalonBay Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AvalonBay Communities, Inc. - AVB

Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of AvalonBay Communities, Inc. (NYSE: AVB) to Equity Residential (NYSE: EQR). KSF is examining whether the offering of 2.793 shares of Equity Residential for each AvalonBay share adequately values the company and if …

AvalonBay, Equity Residential unveil new name as blockbuster merger nears close

As their merger nears completion, AvalonBay Communities Inc. and Equity Residential have announced a new company name: Vivmark Residential. Ben Schall, current CEO of AvalonBay, will lead the newly formed entity. The name Vivmark is derived from the Latin word "vivere," meaning "to live."

AvalonBay and Equity Residential Name Combined REIT Vivmark Residential

AvalonBay Communities Inc. (NYSE: AVB) and Equity Residential (NYSE: EQR) have announced Vivmark Residential as the name for their combined company after a merger of equals. This new entity is expected to form the largest publicly traded multifamily real estate platform in the U.S., …

AvalonBay and Equity Residential name merged firm Vivmark By Investing.com

AvalonBay Communities and Equity Residential announced their merged entity will be named Vivmark Residential, trading under VMRK on the NYSE. The combined company will have an equity market capitalization of approximately $53 billion and an enterprise value of $71 billion, operating over 180,000 rental …

Mid-America Apartment Communities, Inc. Q2 2026 Earnings Call Summary

Mid-America Apartment Communities (MAA) reported Q2 2026 earnings exceeding expectations, driven by strong expense control and improved lease rates. The company saw significant inbound migration and absorption, benefiting from single-family affordability challenges and strategic diversification. While new resident lease rates are recovering slower than …

Glen Eagle Advisors LLC Trims Stake in AvalonBay Communities, Inc. $AVB

Glen Eagle Advisors LLC significantly reduced its stake in AvalonBay Communities (NYSE:AVB) by 95.3% in the first quarter, now holding 264 shares worth $43,000. Despite this, institutional investors still own a substantial 92.61% of the company, with several other hedge funds increasing their positions. …

Avalo Therapeutics, Inc. SEC Filing (Jul 29, 2026)

This article reports on Avalo Therapeutics, Inc.'s SEC filing, specifically an EFFECT filing dated July 29, 2026. The filing indicates a "Neutral" impact and sentiment. It details that the filing is a Notice of Effectiveness for Form S-3, with an effectiveness date of July …

Avalo Therapeutics (AVTX) Expected to Post Earnings on Thursday

AvalonBay (AVB) Stock May Be 32% Undervalued Despite Raised Guidance

AvalonBay Communities (AVB) has delivered a 15.1% total return over three years, with a Discounted Cash Flow (DCF) model suggesting the stock is 32.1% undervalued with an intrinsic value of $283 per share. This contrasts with market multiples and P/E ratios (26.6x) that suggest …

Mid-America Apartment Communities (NYSE:MAA) Updates FY 2026 Earnings Guidance

Mid-America Apartment Communities (NYSE:MAA) has updated its FY 2026 earnings guidance, projecting an EPS between $8.41 and $8.65, aligning with analyst consensus. The company's shares rose during midday trading, and it announced a quarterly dividend of $1.53 per share, yielding 4.5% annually. Analysts generally …

Vox Valor Capital Limited Revenue Breakdown – LSE:VOX

Avalo Therapeutics (AVTX) CMO sells 1,000 shares after option exercise

Avalo Therapeutics' Chief Medical Officer, Mittie Doyle, exercised 1,000 stock options at $12.65 per share and subsequently sold all 1,000 shares at $20.00 each on July 27, 2026. This transaction, executed under a Rule 10b5-1 trading plan, resulted in an approximate pre-tax spread of …

AvalonBay Communities Number of Employees 2026 | Employee Count & Headcount Data

AvalonBay Communities, Inc. (AVB) had approximately 3,055 employees worldwide as of March 2026, marking a 0.3% decline from 2023. The company is actively hiring, with 415 job postings in 2026, a 48.5% increase from 2025. The workforce is primarily concentrated in the United States, …

Adelante Capital Management LLC Acquires 7,271 Shares of AvalonBay Communities, Inc. $AVB

Adelante Capital Management LLC increased its stake in AvalonBay Communities (NYSE:AVB) by 2.3% in the first quarter, purchasing 7,271 additional shares and bringing its total holdings to 325,177 shares valued at $53.1 million. The real estate investment trust currently holds a consensus "Hold" rating …

Avalo Therapeutics Inc (AVTX) Institutional Confidence

Avalo Therapeutics Inc (AVTX) has an institutional shareholding score of 5.00, placing it 132nd out of 385 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 60.06%, a 20.42% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 3.72% of …

Empyrean Capital Partners LP Buys Shares of 58,000 AvalonBay Communities, Inc. $AVB

Empyrean Capital Partners LP has acquired a new stake of 58,000 shares in AvalonBay Communities, Inc. (NYSE:AVB) during the first quarter, valued at approximately $9.47 million. Other institutional investors also increased their holdings in the real estate investment trust. Despite these purchases, AVB stock …

Exome Asset Management LLC Makes New $2.38 Million Investment in Avalo Therapeutics, Inc. $AVTX

Avalon Technologies Schedules Q1 Earnings Call on August 5 at 3:30 PM IST

Avalo Therapeutics Inc (AVTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Avalo Therapeutics Inc (AVTX) stock information, focusing on its dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists several merger-related stock splits that occurred …

BlackRock Inc. (AVTX) discloses 6.5% Avalo Therapeutics stake on Schedule 13G

BlackRock, Inc. has disclosed a passive ownership stake of 6.5% in Avalo Therapeutics Inc. common stock, as reported in a Schedule 13G filing. This amounts to 3,415,731 beneficially owned shares, with BlackRock retaining sole voting power over 3,371,733 shares and sole dispositive power over …

Avalo Therapeutics Inc (AVTX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Avalo Therapeutics Inc (AVTX), noting its current valuation score of 6.96, which ranks 268 out of 386 in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -3.50, which is significantly below …

First Trust Advisors LP Has $48.75 Million Stock Holdings in AvalonBay Communities, Inc. $AVB

First Trust Advisors LP increased its stake in AvalonBay Communities, Inc. (NYSE:AVB) by 6.4% in the first quarter, bringing its total holdings to $48.75 million. Other institutional investors have also made changes to their positions, with overall institutional ownership at 92.61%. Analysts have a …

Carronade Capital Management LP Reduces Stock Holdings in AvalonBay Communities, Inc. $AVB

Carronade Capital Management LP decreased its stake in AvalonBay Communities Inc. (AVB) by 21.3% in the first quarter, selling 11,148 shares and retaining 41,180 shares valued at $6.7 million. Despite this reduction, institutional ownership remains high at 92.61%, with other major investors such as …

Orbimed Advisors LLC Has $7.09 Million Stock Position in Avalo Therapeutics, Inc. $AVTX

AvalonBay Communities, Inc. (NYSE:AVB) Receives Consensus Rating of "Hold" from Analysts

AvalonBay Communities (NYSE:AVB) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $196.80. The real estate investment trust recently reported Q2 EPS of $1.11, missing estimates, but revenue exceeded expectations at $777.77 million. The company also declared a …

Avalo Therapeutics Inc Revenue Breakdown – TRADEGATE:C6K0

Avalo Therapeutics Inc (C6K0) generated 50.23K EUR in revenue last year, primarily from its Pharmaceutical segment, which is a decrease from 426.00K EUR the previous year. All reported revenue for the company came from the United States. The company's financial performance shows a significant …

AvalonBay Communities (AVB) Q4 2023 Earnings Report - Results, Call & Slides

AvalonBay Communities, Inc. $AVB Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio reduced its stake in AvalonBay Communities (NYSE:AVB) by 12.9% in the first quarter, though it still holds over 211,000 shares valued at approximately $34.6 million. The real estate investment trust reported mixed Q1 results, with earnings per share …

AVB4492279 Bond Profile — Key Metrics

This article provides a detailed profile of the AVB4492279 bond issued by AvalonBay Communities, Inc. Key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate are highlighted. It also includes a brief description of AvalonBay Communities, Inc., which is …

AVTX|Avalo Therapeutics Inc|Price:18.210|Chg%:+0.450

Avalo Therapeutics Inc. (AVTX) is a clinical-stage biotechnology company focusing on immune dysregulation, with its lead asset AVTX-009 targeting inflammatory diseases like hidradenitis suppurativa. The company exhibits stable fundamentals, high growth potential, and is considered fairly valued by analysts, with a strong buy rating …

Cantor Fitzgerald reiterates Avalo Therapeutics stock rating

Cantor Fitzgerald has reiterated an Overweight rating on Avalo Therapeutics (NASDAQ:AVTX), with the stock having surged 168% over the past year. The firm's analysis focused on Avalo's abdakibart (IL-1b) Phase 2 data and the upcoming Phase 3 trial for hidradenitis suppurativa, alongside implications from …

AvalonBay Communities, Inc. Revenue Breakdown – NYSE:AVB

This article provides a revenue breakdown for AvalonBay Communities, Inc. (NYSE: AVB). In the last year, the company generated $3.05 billion USD, with the "Same Store" segment contributing the most at $2.74 billion USD. The United States was the primary geographic contributor, accounting for …

AvalonBay, Equity Residential beat FFO estimates in Q2

AvalonBay (AVB) and Equity Residential (EQR) both surpassed Funds From Operations (FFO) estimates in Q2, indicating strength in the multifamily market, particularly in San Francisco and New York City. Both companies have raised their full-year guidance, driven by improving rents and lower operating expenses. …